Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
7
self-reported 2–10 band
Founded
2020
6 years
Legal entities
None matched
Office countries
1
1 address
Funding rounds
2
Pre seed · Nov 2024 · US$ 1.1M
Company type
Privately Held
self-reported
Description
Engineering the Future of Precision Longevity
At vivaLAB, we move precision healthcare out of the laboratory & into daily life. We provide an AI-driven ecosystem empowering individuals to manage their biology with the rigour usually reserved for high-stakes finance. Our mission is dual-focused: to deliver the world’s most advanced "Health span" program & to build a proprietary, longitudinal data asset that redefines chronic disease prevention.
The vivaBALANCE Ecosystem: Precision at Scale
Our flagship product, vivaBALANCE, is a "closed-loop" system designed to eliminate guesswork. It delivers a clinical experience entirely from home:
1. Deep-Data Assessment: Comprehensive microbiome, metabolic, and clinical baselining 2. Seamless Delivery: Personalised supplements delivered in daily sachets, supported by targeted nutritional recommendations.
3. Behavioural Nurturing: Longevity is a habit. Our platform uses AI-driven nudges between test cycles to ensure adherence & sustained engagement 4. Continuous Optimisation: We re-test every 6 months. As your data evolves, we recalibrate your protocol to ensure you stay in the optimal zone
Competitive Advantage: The "Living" Data Moat
While the industry relies on static omics, vivaLAB leverages Multi-Omics to capture the living state of health. By tracking fluid biomarkers, we are architecting a "Biological Twin"—a predictive model to simulate how unique physiology interacts with organ systems to forecast responses to interventions.
Value Beyond Wellness
vivaLAB is building a proprietary database of novel datasets with significant material value. Capturing longitudinal data across biological layers creates a foundation for:
1. New consumer-led Precision Health products 2. Novel Biomarker Discovery 3. Strategic Partnerships
The Vision
We are building the tools to map individual cellular biology, disrupt the reactive healthcare model, & turn the prevention of chronic disease into a manageable, data-driven science.
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
Addresses
- AU655 Elizabeth St; Melbourne, Victoria 3000Primary
Grid intelligence Members
Funding
Last round · 1 November 2024US$ 1.1MPre seed
Rounds2
Round typePre seed · venture round
Amount (USD)1,100,000
Stage rank1
Investors named0
Since last round1 yr 2 mo
Funding
Show as table · 2 funding rounds
| Rounds | 2 |
|---|---|
| Axis | 2020 to 2026 |
| Pre seed · 1 Nov 2024 | US$ 1.1M |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
The people relation is never requested, so there is nothing here to unlock.
FAQ
How many people work at vivaLAB?
7 counted staff profiles at January 2026, inside the self-reported 2–10 band.
Where does vivaLAB have offices?
One address on record, Australia only. Primary: 655 Elizabeth St, Melbourne, Victoria 3000.
Has vivaLAB raised funding?
Two rounds. Latest 1 November 2024: pre seed, US$1,100,000.
Which companies are listed alongside vivaLAB?
5 profiles list vivaLAB as a peer — 78th percentile in Health and Human Services. It lists ten peers of its own. Cincera Therapeutics Pty Ltd and PremieHealth list it back.